欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DK/H/0279/001
药品名称Daivobet
活性成分
    • betamethasone dipropionate 0.5 mg/g
    • calcipotriol hydrate 50.0 µg/g
剂型Ointment
上市许可持有人LEO Pharma A/S Industriparken 55 2750 Ballerup Denmark
参考成员国 - 产品名称Denmark (DK)
互认成员国 - 产品名称
    • Ireland (IE)
    • France (FR)
    • Spain (ES)
      DAIVOBET Pomada
    • Portugal (PT)
      Daivobet
    • Italy (IT)
    • Norway (NO)
    • Finland (FI)
    • Sweden (SE)
      Daivobet
    • Slovenia (SI)
    • Poland (PL)
      Daivobet
    • Latvia (LV)
    • Malta (MT)
    • Lithuania (LT)
      Daivobet 50 mikrogramų/0,5 mg/g tepalas
    • Estonia (EE)
    • Hungary (HU)
      Daivobet kenőcs
    • Cyprus (CY)
      DOVOBET OINTMENT
    • Romania (RO)
      Daivobet 50 micrograme/ 0.5 mg/g unguent
    • Germany (DE)
      Daivobet Salbe
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
许可日期2001/11/27
最近更新日期2024/04/22
药物ATC编码
    • D07XC01 betamethasone
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Fixed Combination Article 4.8b
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase